ARIPIPRAZOLE SANDOZ 30

Pays: Israël

Langue: anglais

Source: Ministry of Health

Achète-le

Notice patient Notice patient (PIL)
11-10-2021

Ingrédients actifs:

ARIPIPRAZOLE

Disponible depuis:

NOVARTIS ISRAEL LTD

Code ATC:

N05AX12

forme pharmaceutique:

TABLETS

Composition:

ARIPIPRAZOLE 30 MG

Mode d'administration:

PER OS

Type d'ordonnance:

Required

Fabriqué par:

LEK PHARMACEUTICALS D.D., SLOVENIA

Domaine thérapeutique:

ARIPIPRAZOLE

indications thérapeutiques:

Aripiprazole Sandoz is indicated for the treatment of schizophrenia, for the treatment of moderate to severe manic episodes in Bipolar I disorder and for the prevention of a new manic episode in patient who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment

Date de l'autorisation:

2019-11-27

Notice patient

                                ARI APL May 21 CL
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS' REGULATIONS
(PREPARATIONS) - 1986
This medicine is dispensed with a doctor’s prescription only
It is advisable to have a person close to you read this leaflet.
ARIPIPRAZOLE SANDOZ
® 5
ARIPIPRAZOLE SANDOZ
® 10
ARIPIPRAZOLE SANDOZ
® 15
ARIPIPRAZOLE SANDOZ
® 30
Tablets
ACTIVE INGREDIENT AND ITS QUANTITY:
Each tablet of ARIPIPRAZOLE SANDOZ 5 contains aripiprazole 5 mg, and
also contains 71.02 mg
lactose monohydrate.
Each tablet of ARIPIPRAZOLE SANDOZ 10 contains aripiprazole 10 mg, and
also contains 65.97 mg
lactose monohydrate.
Each tablet of ARIPIPRAZOLE SANDOZ 15 contains aripiprazole 15 mg, and
also contains 97.75 mg
lactose monohydrate.
Each tablet of ARIPIPRAZOLE SANDOZ 30 contains aripiprazole 30 mg, and
also contains 196.50
mg lactose monohydrate.
For the list of inactive ingredients and allergens, please see section
"Important information about
some of this medicine’s ingredients" and section 6 "Additional
information".
READ THE ENTIRE LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE. This leaflet contains
concise information about this medicine. If you have any further
questions, consult your doctor or
pharmacist.
This medicine has been prescribed to treat your illness. Do not pass
it on to others. It may harm
them, even if it seems to you that their medical condition is similar
to yours.
The medicine is not intended for children below the age of 6.
1. WHAT IS ARIPIPRAZOLE SANDOZ INTENDED FOR?
ARIPIPRAZOLE SANDOZ 5, 10, 15, 30 are intended:
For treatment of schizophrenia.
For treatment of moderate to severe manic states in bipolar disorder
type 1 and for the prevention
of new manic episodes in patients who predominantly experienced manic
episodes and whose
previous manic episodes responded to aripiprazole treatment.
In addition, ARIPIPRAZOLE SANDOZ 5, 10, 15 are intended:
For combined treatment of major depressive disorder (MDD) in patients
who experienced a
partial response to treatment with antidepressants.
ARI APL May 21 
                                
                                Lire le document complet
                                
                            

Documents dans d'autres langues

Notice patient Notice patient arabe 11-10-2021
Notice patient Notice patient hébreu 22-11-2023

Rechercher des alertes liées à ce produit

Afficher l'historique des documents